Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report
Hydroxychloroquine (HCQ) is a widely used drug to treat patients with coronavirus disease 19 (COVID-19). Although evidence of its efficacy and safety remains limited and controversial, both cardiac and non-cardiac adverse events are known to be associated with its use. To our knowledge, electrical s...
Main Authors: | Francesco Vetta, Leonardo Marinaccio, Giampaolo Vetta, Domenico Marchese |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-11-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X20974217 |
Similar Items
-
Alternative sites of ventricular pacing: His bundle pacing
by: Francesco Vetta, et al.
Published: (2020-04-01) -
Hydroxychloroquine and QTc: beyond COVID-19
by: Alberto Castagna, et al.
Published: (2020-10-01) -
Anticoagulation therapy in the elderly with non-valvular atrial fibrillation: a double-edged sword
by: Francesco Vetta, et al.
Published: (2017-07-01) -
Prognostic impact of frailty in elderly cardiac surgery patients
by: Francesco Vetta, et al.
Published: (2017-07-01) -
Cardiac resynchronization therapy in the elderly. How much is it safe and beneficial?
by: Francesco Vetta, et al.
Published: (2019-03-01)